Effect of  Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia 背景：Torcetrapib是一种胆固醇酯转换蛋白（CETP）抑制剂，通过升高HDL-C而可能对动脉粥样硬化性血管疾病产生....

      SPARCL研究的最新分析是为了评估针对最近发生卒中或小卒中的患者采用80mg的阿托伐他汀治疗能否带来明显的冠状动脉事件的保护作用。在850多例试验期间患有再发卒中或小卒中的患者中， 与安慰剂组相比较，80mg阿托伐他汀治疗能使....

Lipitor Provides Unprecented Cardiovascular Risk Rwductions in Diabetes Patients with Metabolic Syndrome and Stroke Patients 已证明阿托伐他汀是惟一的一种他汀药物，可单独用于....

Effect of torcetrapib on the progression of coronary 背景：高密度脂蛋白胆固醇（HDL-C）与心血管危险密切相关。Torcetrapib是一种胆固醇酯转换蛋白（CETP）抑制剂，可升高HDL-C水平，但其升高HDL-C的机制仍不清楚。方法：研究....

背景: 尽管采取了强有力的抗血小板和抗凝血酶治疗，在经PCI治疗的患者中一直存在围手术期和手术后期的不良临床事件。TRA-PCI试验是一项包括2个阶段的，随机，双盲，安慰剂对照的试验研究，其目的就是为了评估口服的凝血酶受体抑制剂（TRA）SCH 530348在行非急性PCI术患者中的安全性和耐受性。....

  Effects of Ramipril and Rosiglitazone on Atherosclerosis: The Study of Atherosclerosis with Ramipril  背景: 肾素－血管紧张素系统的激活和糖代谢的异常在动脉粥样硬化中发....

Results of a Multinational Randomized, Double-Blind, Placebo-Controlled Study of a Novel Thrombin Receptor Antagonist (SCH 530348) in Percutaneous C....

Randomized, Double Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Eplerenone on Ventricular Remodeling in Patients with Left Ve....

A Long-term Prospective Randomized Control Study Using Repetitive Education at 6 Months Intervals and Monitoring for Heart Failure Outpatients - The R....

A double-blind, randomized, placebo controlled clinical trial of allogeneic mesenchymal stem cells for the treatment of patients with acute myocardial....